Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer's disease.

MLA

Charou, Despoina, et al. “Comprehensive Characterization of the Neurogenic and Neuroprotective Action of a Novel TrkB Agonist Using Mouse and Human Stem Cell Models of Alzheimer’s Disease.” Stem Cell Research & Therapy, vol. 15, no. 1, July 2024, p. 200. EBSCOhost, https://doi.org/10.1186/s13287-024-03818-w.

APA

Charou, D., Rogdakis, T., Latorrata, A., Valcarcel, M., Papadogiannis, V., Athanasiou, C., Tsengenes, A., Papadopoulou, M. A., Lypitkas, D., Lavigne, M. D., Katsila, T., Wade, R. C., Cader, M. Z., Calogeropoulou, T., Gravanis, A., & Charalampopoulos, I. (2024). Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease. Stem Cell Research & Therapy, 15(1), 200. https://doi.org/10.1186/s13287-024-03818-w

Chicago

Charou, Despoina, Thanasis Rogdakis, Alessia Latorrata, Maria Valcarcel, Vasileios Papadogiannis, Christina Athanasiou, Alexandros Tsengenes, et al. 2024. “Comprehensive Characterization of the Neurogenic and Neuroprotective Action of a Novel TrkB Agonist Using Mouse and Human Stem Cell Models of Alzheimer’s Disease.” Stem Cell Research & Therapy 15 (1): 200. doi:10.1186/s13287-024-03818-w.